GERMANY - KfW joins other VCs in backing Protagen AG

Kreditanstalt für Wiederaufbau (KfW) has joined existing lead investors MIG AG and Co KG Beteiligungsfonds 3 and S-Venture Capital Dortmund GmbH in raising EUR 1m in interim financing for protein research company Protagen AG. This is the third round of funding for the company. Protagen is a provider of products, services and software solutions for protein research. Recently, Protagen has received a BioChance Plus grant from the German government to identify biomarkers for multiple sclerosis and rheumatoid arthritis. The company is headquartered in Dortmund, and has a second office in New Jersey, US. At present, it employs a staff of 25.